Abstract
The European Association of Tissue Banks (EATB) donor case workshop is a forum held within the program of the EATB annual congress. The workshop offers an opportunity to discuss and evaluate possible approaches taken to challenging situations regarding donor selection. Donor case workshops actively engage participants with diverging background and experience in an informal, secure and enjoyable setting. The resulting discussion with peers promotes consensus development in deciding tissue donor acceptability, especially when donor health issues are not conclusively addressed in standards and regulations. Finally the workshop serves to strengthen the professional tissue banking networks across Europe and beyond. This report reflects some of the discussion at the workshop during the annual congress in Lund, Sweden, in 2014. The cases presented demonstrate that the implications of various donor illnesses, physical findings and behaviours on the safety of tissue transplantation, may be interpreted in a different way by medical directors and other professionals of different tissue facilities. This will also result in diverging preventive measures and decisions taken by the tissue facilities. Some of the donor cases illustrate varied responses from participants and demonstrate that operating procedures, regulations and standards cannot comprehensively cover all tissue donor illnesses, medical histories and circumstances surrounding the cause of death. For many of the issues raised, there is a lack of published scientific evidence. In those cases, tissue bank medical director judgement is critical to guarantee transplantation safety. This judgement should be based on a proper and documented risk assessment case by case. Conditions or parameters taken into account for risk assessment are amongst others, the type of tissue, the type of processing, the characteristics of the final product, and the availability of an adequate sterilisation methodology. By publishing these difficult donor suitability cases, and the resulting discussions, we provide information for future similar cases and we identify needs for future literature review and scientific research. In this way the donor case workshops play a role in optimizing the quality and security of tissue donation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beele H, Van Wijk M, Parker R, Sánchez-Ibáňez J, Brubaker S, Wulff B, Richters C, Cox M, Warwick RM, Eastlund T (2013) Report of the clinical donor case workshop of the European Association of Tissue Banks annual meeting 2012. Cell Tissue Bank 14:561–570
Byard RW, Cains G, Simpson E, Eitzen D, Tsokos M (2006) Drowning, haemodilution, haemolysis and staining of the intima of the aortic root—preliminary observations. J Clin Forensic Med 13(3):121–124
Cannon MJ, Schmid DS, Hyde TB (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20(4):202–213
Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ (2011) National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol 18(11):1895–1899. doi:10.1128/CVI.05228-11
Fernández-Ruiz M, Andrés A, López-Medrano F, González E, Lumbreras C, San-Juan R, Morales JM, Aguado JM (2013) Infection risk in kidney transplantation from uncontrolled donation after circulatory death donors. Transplant Proc 45(4):1335–1338. doi:10.1016/j.transproceed.2013.01.080
Hoetzenecker K, Ankersmit HJ, Lang G, Scheed A, Marta G, Jaksch P, Klepetko W (2012) Considerations on infectious complications using a drowned lung for transplantation. J Heart Lung Transplant 31(10):1144–1146. doi:10.1016/j.healun.2012.08.007
Lee TJ, Fox MP, Trivedi J, van Berkel V (2010) Donors with a history of cocaine use and lung transplant outcomes. Transpl Int 23(7):e32–e34. doi:10.1111/j.1432-2277.2010.01099.x
Matthys C (2014) Cord blood bank, Ghent, Belgium, personal communication
O’Brien SF, Xi G, Yi QL, Goldman M (2010) Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use. Transfus Med 20(1):15–21. doi:10.1111/j.1365-3148.2009.00969.x
Rahav G, Gabbay R, Ornoy A et al (2007) Primary versus nonprimary cytomegalovirus infection during pregnancy, Israel. Emerg Infect Dis 13(11):1791–1793
Saegeman VSM, Chandrasekar A, Vanwijck M, Beele H, Montenero M, Navarro A, Van Geyt C, Bokhorst AG, Fehily D, Warwick RM (2009) EATB donor case workshop 2007. Cell Tissue Bank 10:351–357
Shea KJ, Sopko NA, Ludrosky K, Hoercher K, Smedira NG, Taylor DO, Starling RC, Gonzalez-Stawinski GV (2007) The effect of a donor’s history of active substance on outcomes following orthotopic heart transplantation. Eur J Cardiothorac Surg 31(3):452–456 (discussion 456)
Trias E (2014) Tissue Bank, Barcelona, Spain, personal communication
van Wijk MJ, Poniatowski S, Fehily D, Brubaker SA, Eastlund T, Kurz J, Parker R, Beele H, Herson MR, Monig HJ, Chandrasekar A, Holovská V, Wysocka-Wycisk A, Brown MS, Winstanley E, Sánchez-Ibáňez J, Warwick RM (2012) Results of the clinical donor case and quality system case workshops of the European Association of Tissue Banks annual meeting 2009. Cell Tissue Bank 13(1):191–202. doi:10.1007/s10561-011-9263-3
van Wijk MJ, Beele H, Brubaker SA, Navarro A, Wulff B, Warwick RM (2015) Report of the clinical donor case workshop of the European Association of Tissue Banks annual congress 2013. Cell Tissue Bank 16(3):449–455. doi:10.1007/s10561-014-9490-5
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beele, H., van Wijk, M.J., Wulff, B. et al. Report of the clinical donor case workshop of the European Association of Tissue Banks annual meeting 2014. Cell Tissue Bank 17, 353–360 (2016). https://doi.org/10.1007/s10561-016-9571-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-016-9571-8